KDventures portfolio company Modus Therapeutics raises SEK 7.6 million in directed share issue

Reuters2026/09/04 11:10

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

KDventures portfolio company Modus Therapeutics raised SEK 7.6 million in a directed share issue to fund sevuparin development in 2027.
The company issued 20,000,000 shares at SEK 0.38 each, before transaction costs.
Proceeds earmarked for manufacturing supply, severe-malaria research collaboration work, and business development tied to phase 2a CKD anemia readout.
KDventures’ stake in Modus Therapeutics stands at 51% following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KDventures AB published the original content used to generate this news brief on September 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

KDventures portfolio company Modus Therapeutics raises SEK 7.6 million in directed share issue

You may also like

Crypto prices